Robert J. Hamilton
Robert J. Hamilton
Princess Margaret Cancer Centre
Verified email at
Cited by
Cited by
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
FR Schumacher, AA Al Olama, SI Berndt, S Benlloch, M Ahmed, ...
Nature genetics 50 (7), 928-936, 2018
Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer
LL Banez, RJ Hamilton, AW Partin, RT Vollmer, L Sun, C Rodriguez, ...
Jama 298 (19), 2275-2280, 2007
Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction
DV Conti, BF Darst, LC Moss, EJ Saunders, X Sheng, A Chou, ...
Nature genetics 53 (1), 65-75, 2021
Comprehensive audiometric analysis of hearing impairment and tinnitus after cisplatin-based chemotherapy in survivors of adult-onset cancer
RD Frisina, HE Wheeler, SD Fossa, SL Kerns, C Fung, HD Sesso, ...
Journal of Clinical Oncology 34 (23), 2712, 2016
DNA hypermethylation within TERT promoter upregulates TERT expression in cancer
DD Lee, R Leao, M Komosa, M Gallo, CH Zhang, T Lipman, M Remke, ...
The Journal of clinical investigation 129 (1), 223-229, 2019
The influence of statin medications on prostate-specific antigen levels
RJ Hamilton, KC Goldberg, EA Platz, SJ Freedland
JNCI: Journal of the National Cancer Institute 100 (21), 1511-1518, 2008
Statin medication use and the risk of biochemical recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) Database
RJ Hamilton, LL Banez, WJ Aronson, MK Terris, EA Platz, CJ Kane, ...
Cancer 116 (14), 3389-3398, 2010
The current evidence on statin use and prostate cancer prevention: are we there yet?
MA Alfaqih, EH Allott, RJ Hamilton, MR Freeman, SJ Freedland
Nature Reviews Urology 14 (2), 107-119, 2017
Serum miRNA predicts viable disease after chemotherapy in patients with testicular nonseminoma germ cell tumor
R Lećo, T van Agthoven, A Figueiredo, MAS Jewett, K Fadaak, J Sweet, ...
The Journal of urology 200 (1), 126-135, 2018
Dissecting the association between metabolic syndrome and prostate cancer risk: analysis of a large clinical cohort
B Bhindi, J Locke, SMH Alibhai, GS Kulkarni, DS Margel, RJ Hamilton, ...
European urology 67 (1), 64-70, 2015
Impact of the US Preventive Services Task Force recommendations against prostate specific antigen screening on prostate biopsy and cancer detection rates
B Bhindi, M Mamdani, GS Kulkarni, A Finelli, RJ Hamilton, J Trachtenberg, ...
The Journal of urology 193 (5), 1519-1524, 2015
Shared heritability and functional enrichment across six solid cancers
X Jiang, HK Finucane, FR Schumacher, SL Schmit, JP Tyrer, Y Han, ...
Nature communications 10 (1), 431, 2019
Cumulative burden of morbidity among testicular cancer survivors after standard cisplatin-based chemotherapy: a multi-institutional study
SL Kerns, C Fung, PO Monahan, S Ardeshir-Rouhani-Fard, MI Abu Zaid, ...
Journal of Clinical Oncology 36 (15), 1505-1512, 2018
Hidden barriers between knowledge and behavior: the North Carolina prostate cancer screening and treatment experience
JA Talcott, P Spain, JA Clark, WR Carpenter, YK Do, RJ Hamilton, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 2007
Developing a highly specific biomarker for germ cell malignancies: plasma miR371 expression across the germ cell malignancy spectrum
L Nappi, M Thi, A Lum, D Huntsman, BJ Eigl, C Martin, B O’Neil, ...
Journal of clinical oncology 37 (33), 3090, 2019
Multi-institutional assessment of adverse health outcomes among North American testicular cancer survivors after modern cisplatin-based chemotherapy
C Fung, HD Sesso, AM Williams, SL Kerns, P Monahan, M Abu Zaid, ...
Journal of Clinical Oncology 35 (11), 1211-1222, 2017
Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants
T Dadaev, EJ Saunders, PJ Newcombe, E Anokian, DA Leongamornlert, ...
Nature communications 9 (1), 2256, 2018
Metastatic renal cell carcinoma: Patterns and predictors of metastases—A contemporary population-based series
T Chandrasekar, Z Klaassen, H Goldberg, GS Kulkarni, RJ Hamilton, ...
Urologic Oncology: Seminars and Original Investigations 35 (11), 661. e7-661 …, 2017
Statin use and risk of prostate cancer and high-grade prostate cancer: results from the REDUCE study
SJ Freedland, RJ Hamilton, L Gerber, LL Banez, DM Moreira, GL Andriole, ...
Prostate cancer and prostatic diseases 16 (3), 254-259, 2013
Cancer stem cells in prostate cancer: implications for targeted therapy
R Lećo, C Domingos, A Figueiredo, R Hamilton, U Tabori, ...
Urologia internationalis 99 (2), 125-136, 2017
The system can't perform the operation now. Try again later.
Articles 1–20